AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Dainippon Sumitomo Pharma has reported on major products under development in Japan (as of 31 Jul 2009). NDA filed (miriplatin hydrate, metformin hydrochloride, and meropenem hydrate), Phase III …